This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jun;85(6):401-2.

doi: 10.1002/ajh.21733.

Hydroxyurea in sickle cell disease: What will it take to change practice?

George F Atweh¹

Affiliations

PMID: 20513115
DOI: 10.1002/ajh.21733

Free article

Comment

Hydroxyurea in sickle cell disease: What will it take to change practice?

George F Atweh. Am J Hematol. 2010 Jun.

Free article

. 2010 Jun;85(6):401-2.

doi: 10.1002/ajh.21733.

Author

George F Atweh¹

Affiliation

¹ University of Cincinnati College of Medicine, Ohio 45267-0562, USA. george.atweh@uc.edu

PMID: 20513115
DOI: 10.1002/ajh.21733

No abstract available

PubMed Disclaimer

Comment on

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, Ataga K, Swerdlow P, Kutlar A, DeCastro L, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up. Steinberg MH, et al. Am J Hematol. 2010 Jun;85(6):403-8. doi: 10.1002/ajh.21699. Am J Hematol. 2010. PMID: 20513116 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information